Racial and ethnic disparities in pediatric kidney transplantation have been described in multiple studies, but in December 2014, a U.S. policy change was implemented in part to improve equity in access to transplantation. ...
Oct 21, 2021
0
2
Some experts fear that recent reforms instated by the Centers for Medicare and Medicaid Services may lead to the closure of some dialysis facilities that treat patients with kidney failure. When investigators analyzed data ...
Oct 4, 2021
0
4
Individuals with kidney failure and those who have received a kidney transplant are especially vulnerable to COVID-19 and are thought to have a higher risk of dying from it than adults in the general population. Although ...
Sep 29, 2021
0
10
Patients with kidney failure who are on long-term dialysis often rely on family members or friends to make critical treatment decisions towards the end of life. A study in CJASN examines whether such close contacts have a ...
Sep 10, 2021
0
6
The Patient Activation Measure (PAM) is a standardized instrument that assesses an individual's knowledge, ability, skills, and confidence in self-managing chronic medical conditions. A study published in JASN examined whether ...
Sep 1, 2021
0
2
A recent study has linked weight fluctuations—or body mass index variability—to higher risks of cardiovascular-related problems and early death in adults with chronic kidney disease (CKD). The findings appear in an upcoming ...
Aug 12, 2021
0
10
A recent clinical trial described in CJASN has examined the potential of vitamin D supplementation for protecting the kidney health of individuals with pre-diabetes.
Aug 6, 2021
0
264
Pooled results from recent clinical trials indicate that an oral drug called roxadustat is an effective treatment for anemia in patients with chronic kidney disease. The results are published in an upcoming issue of CJASN.
Aug 6, 2021
0
3
Immune cells called natural killer cells contribute to organ rejection after transplantation because they miss "self" proteins on donor cells, according to a study appearing in an upcoming issue of JASN. A better understanding ...
Jul 22, 2021
0
1
Studies have shown that diabetes drugs called sodium-glucose co-transporter 2 (SGLT2) inhibitors can provide kidney- and cardiovascular-related benefits to individuals with or without diabetes and with or without impaired ...
Jul 17, 2021
0
7
